Log in to save to my catalogue

Rationale and design of a randomized clinical trial of β-blocker therapy (atenolol) versus angiotens...

Rationale and design of a randomized clinical trial of β-blocker therapy (atenolol) versus angiotens...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68316885

Rationale and design of a randomized clinical trial of β-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome

About this item

Full title

Rationale and design of a randomized clinical trial of β-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome

Publisher

New York, NY: Mosby, Inc

Journal title

The American heart journal, 2007-10, Vol.154 (4), p.624-631

Language

English

Formats

Publication information

Publisher

New York, NY: Mosby, Inc

More information

Scope and Contents

Contents

Background Cardiovascular disease, including aortic root dilation, dissection, and rupture, is the leading cause of mortality in patients with Marfan syndrome (MFS). The maximal aortic root diameter at the sinuses of Valsalva is considered the best predictor of adverse cardiovascular outcome. Although advances in therapy have improved life expectan...

Alternative Titles

Full title

Rationale and design of a randomized clinical trial of β-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_68316885

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68316885

Other Identifiers

ISSN

0002-8703

E-ISSN

1097-6744

DOI

10.1016/j.ahj.2007.06.024

How to access this item